Mankind Pharma launches drug for treatment of infertility in India
With the launch, the company has become the first Indian and second global firm to develop the drug, Mankind Pharma said in a statement. The company's product is generic version of Abbott's Duphaston tablets, it added. The manufacturing process of Dydrogesterone is very complex as it involves conversion of natural progesterone, the statement said.
ePharma startups ‘sensitive’ to data Bill definition
Firms seek better definition of ‘sensitive’ health data and guidelines for anonymised data in the Personal Data Protection Bill. The clause on ‘fair and responsible processing’ of data in the Bill also needs to be clarified and cannot be left open to interpretation.
Stocks in news: Sun pharma, Apollo Hospitals, HUL and Jindal steel
Here are the top stocks that are likely to be in focus in today's trading.Stocks in news: Sun pharma, Apollo Hospitals, HUL and Jindal steel
Glenmark gets approval from Australian regulator to commercialise Ryaltris
Glenmark is entitled to receive commercial milestone payments from Seqirus.
2020 will be a year of recovery for broader markets: Chakri Lokapriya
The value unlocking in RIL over next 4-5 years can be significant and double from current levels.
Nifty Pharma set to rally 6-8% in a few weeks
In the last three trading sessions, buying seems to have re-emerged; courtesy to cool off from the global worries.
Dishman Carbogen target price goes up by 100% post I-T raids
Nirmal Bang has a ‘Buy’ call on Dishman Carbogen with a target price of Rs 185. Dishman Carbogen Amcis on Thursday said Income Tax Department has conducted a search at its offices and manufacturing sites and the search operation was concluded on December 25.
Sell Aurobindo Pharma, price target Rs 410: Arun Kumar
The analyst suggested a stoploss at Rs 447.
Share market update: Nifty Pharma index dips; Glenmark Pharma down 2%
The Nifty Pharma index was trading 0.71 per cent down at 8131.70.
Buy Sun Pharmaceutical Industries, price target Rs 455: Sagar Doshi
The analyst suggested a stoploss at Rs 410 .
Natco launches cut price versions of cancer drug ibrutinib in india
The patent for the drug is held by Pharmacyclics for three to four more years in India. Pharmacyclics was globally acquired by US giant AbbVie in 2015 in a massive USD21 billion deal. Natco's latest move is consistent with its earlier launches and challenging the patents held on anti-cancer drugs by multinational drug companies.
Strides Pharma gets tentative nod from USFDA for pain relieving drug
Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United States Food & Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing.
Share market update: Pharma shares gain; Piramal Enterprises up 1%
The Nifty Pharma index was trading 0.71 per cent up at 8014.
After Market: Kolte-Patil surges 14%; metals shine; Pharma, realty decline
India VIX, the index of volatility in the markets, slumped 6.5 per cent to 12.54.
Dishman Carbogen slips 42% in six sessions on I-T raid
The scrip declined nearly 42 per cent in six-sessions to hit an intraday low.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service